(Q37822465)

23 August 2017

1 reference

title

Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers (English)

1 reference

23 August 2017

0 references

2

0 references

author name string

Radu Albulescu

series ordinal

1

1 reference

23 August 2017

Lucian Albulescu

series ordinal

3

1 reference

23 August 2017

Cristiana Tanase

series ordinal

4

1 reference

23 August 2017

publication date

1 January 2011

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

23 August 2017

published in

1 reference

23 August 2017

volume

11

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

101-120

1 reference

Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964-2003 followed up to the end of 2006.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Serum biomarkers of cell death for monitoring therapy response of gastrointestinal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Gastrointestinal cancer: recent developments in medical oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

The role of microRNAs in cancer: no small matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Diagnostic and prognostic microRNAs in stage II colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA signatures as diagnostic and therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

miRNAs as molecular biomarkers of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

miRiad roles for the miR-17-92 cluster in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Switching from repression to activation: microRNAs can up-regulate translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Expression profiling of microRNA using oligo DNA arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNAs: novel biomarkers for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Multiplexed detection methods for profiling microRNA expression in biological samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Functional screening using a microRNA virus library and microarrays: a new high-throughput assay to identify tumor-suppressive microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Technical variables in high-throughput miRNA expression profiling: much work remains to be done

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

miR-21 plays a pivotal role in gastric cancer pathogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Decreased expression of microRNA-143 and -145 in human gastric cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Detection of miR-106a in gastric carcinoma and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Downregulation of microRNA-200 in EBV-associated gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Expression profiling identifies microRNA signature in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

miR-146a suppresses invasion of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Downregulation of miR-122 in the rodent and human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

miR-221 overexpression contributes to liver tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Identification of non-coding RNAs embracing microRNA-143/145 cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA-145 targets YES and STAT1 in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Improvement of tissue preparation for laser capture microdissection: application for cell type-specific miRNA expression profiling in colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Modulation of mismatch repair and genomic stability by miR-155

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA expression profiles of esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

A functional varient in microRNA-146a is associated with risk of esophageal squamous cell carcinoma in Chinese Han

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNAs and esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Assessment of soluble angiogenic markers in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Circulating microRNAs in plasma of patients with gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

c-Myc-regulated microRNAs modulate E2F1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Overlapping expression of microRNAs in human embryonic colon and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Fecal MicroRNAs as novel biomarkers for colon cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNAs in colorectal cancer: translation of molecular biology into clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

HDAC4 promotes growth of colon cancer cells via repression of p21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNAs: control and loss of control in human physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNAs as a new potential therapeutic opportunity in gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

miR-21: a small multi-faceted RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

MicroRNA regulation of cancer stem cells and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

ERBB2 suppression decreases cell growth via apoptosis in gastrointestinal adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Specificity, duplex degradation and subcellular localization of antagomirs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

LNA-mediated microRNA silencing in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

RAS is regulated by the let-7 microRNA family

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

The let-7 microRNA represses cell proliferation pathways in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

microRNAs as oncogenes and tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

siRNA delivery systems for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.10.106

21 January 2018

Identifiers

DOI

10.1586/ERM.10.106

1 reference

23 August 2017

1 reference